Eric J. Bernhard
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism 18
- Oncology top 0.5%
- Cancer-related Molecular Pathways 33
- Molecular Biology top 1%
- Cell death mechanisms and regulation 20
- PI3K/AKT/mTOR signaling in cancer 16
- Ubiquitin and proteasome pathways 9
- Immunology and Allergy top 2%
- Biotechnology top 1%
- Cancer Research and Treatments 8
-
- Effects of Radiation Exposure 9
-
- Lung Cancer Treatments and Mutations 7
- Co-authors
- Ruth J. MuschelW. Gillies McKennaWafik S. El‐DeiryPeiwen FeiAmit MaityStephen B. GruberGeorge J. CernigliaStephen M. Hahn
- Journals
- Cancer Research (10 papers)Radiation Research (9 papers)Clinical Cancer Research (5 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Eric J. Bernhard
101 papers receiving 7.2k citations
Peers
Comparison fields: 5 of 129
- Cancer Research 2.1k
- Oncology 3.0k
- Molecular Biology 4.5k
- Immunology and Allergy 301
- Biotechnology 338
Countries citing papers authored by Eric J. Bernhard
This map shows the geographic impact of Eric J. Bernhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric J. Bernhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric J. Bernhard more than expected).
Fields of papers citing papers by Eric J. Bernhard
This network shows the impact of papers produced by Eric J. Bernhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric J. Bernhard. The network helps show where Eric J. Bernhard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eric J. Bernhard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 59 | |
| 2 | 2011 | 39 | |
| 3 | 2011 | 112 | |
| 4 | 2010 | 100 | |
| 5 | 2009 | 105 | |
| 6 | 2009 | 4 | |
| 7 | 2008 | 106 | |
| 8 | 2006 | 130 | |
| 9 | Decreased survival, chronic inflammation and tumor susceptibility of irradiated DR5-null mice | 2006 | 0 |
| 10 | 2004 | 197 | |
| 11 | 2004 | 23 | |
| 12 | 2004 | 134 | |
| 13 | 2003 | 32 | |
| 14 | 2003 | 114 | |
| 15 | 2003 | 10 | |
| 16 | Phase I trial of the farnesyl protein transferase (FPTASE) inhibitor L-778123 in combination with radiotherapy | 2000 | 1 |
| 17 | 2000 | 58 | |
| 18 | Induction of apoptosis at different oxygen tensions: evidence that oxygen radicals do not mediate apoptotic signaling. | 1995 | 126 |
| 19 | 1995 | 20 | |
| 20 | 1988 | 44 |
About Eric J. Bernhard
Eric J. Bernhard is a scholar working on Cancer Research, Oncology and Biotechnology, having authored 103 papers that have together received 7.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (33 papers), Cell death mechanisms and regulation (20 papers), Cancer, Hypoxia, and Metabolism (18 papers), PI3K/AKT/mTOR signaling in cancer (16 papers), Ubiquitin and proteasome pathways (9 papers), Effects of Radiation Exposure (9 papers), Cancer Research and Treatments (8 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Cancer Research (2.1k citations), Oncology (3.0k citations) and Molecular Biology (4.5k citations). Eric J. Bernhard has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Ruth J. Muschel, W. Gillies McKenna, Wafik S. El‐Deiry, W. Gillies McKenna, Peiwen Fei, Amit Maity, Stephen B. Gruber, George J. Cerniglia, Stephen M. Hahn and Elizabeth Cohen–Jonathan. Their work appears in journals such as Cancer Research, Radiation Research, Clinical Cancer Research, The Journal of Immunology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.